Influence of virulence attenuation on the efficacy of Listeria monocytogenes as a vaccine vector for stimulating anti-tumor immunity

被引:0
|
作者
Smithey, Megan J. [1 ]
Higgins, Darren [2 ]
Freitag, Nancy E. [3 ]
Bouwer, H. G. Archie [1 ,4 ]
机构
[1] Portland VA Med Ctr, Portland, OR USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Illinois, Chicago, IL USA
[4] EACRI, Portland, OR USA
来源
FASEB JOURNAL | 2008年 / 22卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Influence of tumors on protective anti-tumor immunity and the effects of irradiation
    Foulds, Gemma A.
    Radons, Juergen
    Kreuzer, Mira
    Multhoff, Gabriele
    Pockley, Alan G.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [22] Virulence factor p60 of Listeria monocytogenes modulates innate immunity by inducing tumor necrosis factor α
    Sashinami, Hiroshi
    Hu, Dong-Liang
    Li, Sheng-Jun
    Mitsui, Toshihito
    Hakamada, Ken-Ichi
    Ishiguro, Yoh
    Fukuda, Shinsaku
    Nakane, Akio
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2010, 59 (01): : 100 - 107
  • [23] Induction of anti-tumor immunity by intrasplenic administration of a carcinoembryonic antigen DNA vaccine
    White, SA
    LoBuglio, AF
    Arani, RB
    Pike, MJ
    Moore, SE
    Barlow, DL
    Conry, RM
    JOURNAL OF GENE MEDICINE, 2000, 2 (02): : 135 - 140
  • [24] Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
    Page, David B.
    Hulett, Tyler W.
    Hilton, Traci L.
    Hu, Hong-Ming
    Urba, Walter J.
    Fox, Bernard A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
  • [25] Induction of anti-tumor immunity in mice using a syngeneic endothelial cell vaccine
    Scappaticci, FA
    Nolan, GP
    ANTICANCER RESEARCH, 2003, 23 (2B) : 1165 - 1172
  • [26] Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy
    Ramos, J. M.
    Garcia-Sepulcre, M. F.
    Masia, M.
    Brotons, A.
    Grau, M. C.
    Gutierrez, F.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2010, 102 (10) : 614 - U62
  • [27] OMX IS A TUMOR MICROENVIRONMENT MODIFIER THAT RESTORES ANTI-TUMOR IMMUNITY AND IMPROVES ANTI-TUMOR EFFICACY BY REDUCING TUMOR HYPOXIA IN INTRACRANIAL GLIOBLASTOMA MOUSE MODEL
    Le Moan, Natacha
    Davis, Tina
    Leung, Philberta
    Ng, Sarah
    Winger, Jonathan
    Cary, Stephen
    Butowski, Nicholas
    Krtolica, Ana
    NEURO-ONCOLOGY, 2018, 20 : 259 - 259
  • [28] Long-Lasting, Fine-Tuned Anti-Tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules
    Olagunju, Abolaji S.
    Sardinha, Andrew V. D.
    Amarante-Mendes, Gustavo P.
    PATHOGENS, 2024, 13 (10):
  • [29] INFLUENCE OF DIFFERENT ROUTES OF ANTI-TUMOR IMMUNIZATION - ALTERNATIVE INDUCTION OF TUMOR IMMUNITY AND TUMOR ENHANCEMENT
    BAUER, H
    HAYAMI, M
    STEHFENGERVINUS, JC
    JOURNAL OF IMMUNOLOGY, 1979, 122 (03): : 806 - 812
  • [30] A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector
    Zhang, Weijun
    Zhang, Tong
    Turk, Mary-Jo
    Usherwood, Edward J.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010, 59 (05) : 707 - 713